Stereotaxis, Inc. (NASDAQ:STXS)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

Recs

0
Player Avatar Maribaza (26.67) Submitted: 7/13/2010 8:33:37 PM : Underperform Start Price: $4.26 STXS Score: +111.62

19,12,0
28,27,12

Featured Broker Partners


Advertisement